Dupilumab is associated with greater improvement in asthma exacerbations than omalizumab and mepolizumab. Multiple monoclonal…
MDNewsline DailyMay 22, 2023
Asthma treatment varies dramatically worldwide, and this study provides individual-level reporting on medication use and…
MDNewsline DailyMay 18, 2023
Although section 340B of the Public Health Service Act may be effective in other areas,…
MDNewsline DailyMay 18, 2023
Research included a survey showing that people would be likely to use the spray 18…
MDNewsline DailyMay 15, 2023
Key Takeaways Older adults with autism can experience a host of physical and mental ills…
MDNewsline DailyMay 9, 2023
Dupilumab is effective in improving asthma outcomes in patients with coexisting chronic rhinosinusitis and nasal…
MDNewsline DailyApril 24, 2023
Ecleralimab administration is a safe intervention in patients suffering from mild atopic asthma, as it…
MDNewsline DailyApril 24, 2023
Treatment with dupilumab, a monoclonal antibody, significantly improves clinical outcomes and mediates the reversal of…
MDNewsline DailyApril 24, 2023
While the Dyson high-efficiency particulate air purifier significantly improved air quality, the device did not…
MDNewsline DailyApril 14, 2023